Next week the Food and Drug Administration's (FDA) transparency taskforce will be holding a hearing asking for people to comment on the issue at the core of the multi-media investigation we released today, "Heart of the Matter: How Congress and Special Interests Kept Clinical Trial Data Secret":
The topics to be covered are: (1) early communication about emerging safety issues concerning FDA-regulated products, (2) disclosure of information about product applications that are abandoned (which means that no work is being done or will be undertaken to have the application approved) or withdrawn by the applicant before approval, and (emph. added) (3) communication of agency decisions about pending product applications.
Continue readingHow Congress and Special Interests Kept Clinical Trial Data Secret
Meet Bray Patrick-Lake, a 39-year-old mother of two and director of a Colorado nonprofit serving the homeless. In 2008, she... View Article
Continue readingAsk House Speaker Nancy Pelosi About Health Care
Tomorrow morning at 11:30 a.m. Eastern, the Sunlight Foundation joins Blogher in moderating a conference call with House Speaker Nancy... View Article
Continue readingAsk Rep. George Miller About Health Care
Tomorrow I’ll have the honor of moderating a conference call for bloggers with Rep. George Miller on the future of... View Article
Continue readingClinicalTrials.gov missing basic data
Fewer than half of medical clinical trials published in the last year in leading medical journals are reported on the government site ClinicalTrials.gov, according to a new study published by the Journal of the American Medical Association (JAMA).
According to the study, despite a 2005 requirement by medical journal editors that researchers register their studies online before acceptance in a major journal, just 147 out of 323 articles published in the past year were properly registered before the end of the trial. To meet the requirement, researchers are supposed to state what outcomes they will measure to figure out ...
Continue readingHow well do popular drugs work?
Here at Real Time we are beginning to dig into examples of secret data--data the government collects, that could affect our health and safety, but we, the public, can't see.
The U.S. Food and Drug Administration (FDA) is a treasure house of data on the safety and efficacy of prescription drugs. Before a drug company can market a product in this country, it must first submit a plan to test the drug. Agency scientists review and analyze the results once they are submitted. Yet it's not always easy to get your hands on this information.
"One major ...
Continue readingBlogHer teams with Sunlight to get healthcare facts out
This week BlogHer.com, one of the top women’s online networks, is running a special series, “Beyond Mudslinging.” Blogher is inviting... View Article
Continue readingTransportation Dept withheld documents detailing cell phone hazards
Texting or even talking on a cell phone while driving increases the risk of a deadly accident, according to analysis... View Article
Continue readingGrassley feted by alternative med lobbyist
A self-proclaimed lobbyist for an alternative health organization--who left a prominent conservative group more than a decade ago under a cloud of financial mismanagement--is hosting a fundraiser next week for Sen. Chuck Grassley (R-IA). Grassley, who recently earned fame for his tweets on health care, has a reputation as a strong crusader for drug safety. But he has also has championed policies favoring the alternative health industry, which some consumer critics charge is not adequately regulated by the federal government.
Continue readingNon-earmark disclosing lawmakers feted by transportation interests
At least a dozen lawmakers who didn't disclose their transportation earmarks are the beneficiaries of trasnportation fundraisers this year, according to Party Time. Click here to see who. We've also updated this online database to include party information.
Continue reading
59063
